OIG - Office of Inspector General

11/13/2026 | Press release | Archived content

Pleasanton Biotech Company Agrees to Pay Over a Half Million Dollars to Resolve Allegations That It Improperly Obtained Federal Grant Funds

Pleasanton Biotech Company Agrees to Pay Over a Half Million Dollars to Resolve Allegations That It Improperly Obtained Federal Grant Funds

SAN FRANCISCO - Cyion Technologies LLC (Cyion), a Pleasanton-based company involved in biological research and drug discovery, has agreed to pay $528,335.74 to resolve allegations that it violated the False Claims Act by improperly accepting and drawing down funds from federal grant awards that it was ineligible to receive.

Read more on www.justice.gov

Action Details

  • Date:Nov. 13, 2026, 7:49 a.m.
  • Agency:U.S. Attorney's Office, Northern District of California
  • Enforcement Types:
    • Criminal and Civil Actions
OIG - Office of Inspector General published this content on November 13, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 16, 2026 at 12:49 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]